PCK 3.70% 2.8¢ painchek ltd

Ann: Quarterly Update and Appendix 4C, page-101

  1. 458 Posts.
    lightbulb Created with Sketch. 188
    Fair chat. Funding will be required before needed so my $2m projection may be generous.

    8.6.3 suggests they're confident of at least two quarters more funding and thank god as raising below 5c would be horrific. If they can hold out until H2 and deliver great progress (revenue) in the interim which boosts s/p would be critical & make part loan funding more feasible.

    Interesting to see from the June 21 quarterly to last months increases in advertising/marketing (slightly) + staff costs (200k) but decreases in r&d + admin/corporate costs (less tax assessment). Overall decrease in operating expenses but as you mentioned more staff will be required. Deals like the MPS one save in marketing costs etc. Plus the directors are pretty tight in general as we know. Low-cost digital based is the attraction.


 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
0.001(3.70%)
Mkt cap ! $45.80M
Open High Low Value Volume
2.8¢ 2.8¢ 2.7¢ $12.18K 442.9K

Buyers (Bids)

No. Vol. Price($)
2 67222 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 646454 4
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.